CA2939940C - Method for maintenance of urethral catheters - Google Patents
Method for maintenance of urethral catheters Download PDFInfo
- Publication number
- CA2939940C CA2939940C CA2939940A CA2939940A CA2939940C CA 2939940 C CA2939940 C CA 2939940C CA 2939940 A CA2939940 A CA 2939940A CA 2939940 A CA2939940 A CA 2939940A CA 2939940 C CA2939940 C CA 2939940C
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- perineum
- meatus
- insertion site
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract description 48
- 238000012423 maintenance Methods 0.000 title abstract description 21
- 238000003780 insertion Methods 0.000 claims abstract description 69
- 230000037431 insertion Effects 0.000 claims abstract description 67
- 210000002640 perineum Anatomy 0.000 claims abstract description 52
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 51
- 210000004877 mucosa Anatomy 0.000 claims abstract description 40
- 208000019206 urinary tract infection Diseases 0.000 claims abstract description 17
- 206010021639 Incontinence Diseases 0.000 claims abstract description 6
- 210000000434 stratum corneum Anatomy 0.000 claims abstract description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 43
- 230000002485 urinary effect Effects 0.000 claims description 27
- 239000003795 chemical substances by application Substances 0.000 claims description 24
- 230000000845 anti-microbial effect Effects 0.000 claims description 23
- 239000004599 antimicrobial Substances 0.000 claims description 18
- 230000004888 barrier function Effects 0.000 claims description 17
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 210000003708 urethra Anatomy 0.000 claims description 11
- 230000035876 healing Effects 0.000 claims description 10
- 229920000153 Povidone-iodine Polymers 0.000 claims description 8
- 239000003906 humectant Substances 0.000 claims description 8
- 229960001621 povidone-iodine Drugs 0.000 claims description 8
- 239000003974 emollient agent Substances 0.000 claims description 7
- 230000001737 promoting effect Effects 0.000 claims description 7
- 210000000987 immune system Anatomy 0.000 claims description 5
- -1 quaternary ammonium ions Chemical class 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 230000007760 free radical scavenging Effects 0.000 claims description 4
- 230000001937 non-anti-biotic effect Effects 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000002516 radical scavenger Substances 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 238000011109 contamination Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- 239000004088 foaming agent Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 56
- 230000002378 acidificating effect Effects 0.000 abstract description 9
- 241000124008 Mammalia Species 0.000 abstract description 2
- 230000000737 periodic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 92
- 239000000243 solution Substances 0.000 description 69
- 229940111068 theraworx Drugs 0.000 description 26
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 20
- 238000011282 treatment Methods 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 19
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 15
- 229920002498 Beta-glucan Polymers 0.000 description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- 210000004207 dermis Anatomy 0.000 description 12
- 210000002615 epidermis Anatomy 0.000 description 12
- 244000144927 Aloe barbadensis Species 0.000 description 11
- 235000002961 Aloe barbadensis Nutrition 0.000 description 11
- 238000005299 abrasion Methods 0.000 description 11
- 235000011399 aloe vera Nutrition 0.000 description 11
- 239000004744 fabric Substances 0.000 description 11
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 10
- 229960000458 allantoin Drugs 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000010374 citricidal Substances 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- 229940064804 betadine Drugs 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000012678 infectious agent Substances 0.000 description 6
- 230000002458 infectious effect Effects 0.000 description 6
- 230000037311 normal skin Effects 0.000 description 6
- 230000000474 nursing effect Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 208000002874 Acne Vulgaris Diseases 0.000 description 5
- 206010000496 acne Diseases 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 201000004538 Bacteriuria Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229940064004 antiseptic throat preparations Drugs 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000011418 maintenance treatment Methods 0.000 description 4
- 210000003899 penis Anatomy 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 208000034347 Faecal incontinence Diseases 0.000 description 3
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 3
- 238000003070 Statistical process control Methods 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 229920002770 condensed tannin Polymers 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 229940087603 grape seed extract Drugs 0.000 description 3
- 235000002532 grape seed extract Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 235000018192 pine bark supplement Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940106796 pycnogenol Drugs 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000001717 vitis vinifera seed extract Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 208000035867 Candiduria Diseases 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000005202 decontamination Methods 0.000 description 2
- 230000003588 decontaminative effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 108010005335 mannoproteins Proteins 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000008470 skin growth Effects 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WOFTVESNUIDLHD-UHFFFAOYSA-N (2,4-dioxoimidazolidin-1-yl)urea Chemical compound NC(=O)NN1CC(=O)NC1=O WOFTVESNUIDLHD-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- 229930000083 3-dehydroretinol Natural products 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 206010056396 Asymptomatic bacteriuria Diseases 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 101001047783 Homo sapiens Histone PARylation factor 1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010062903 Urethritis noninfective Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000015946 suckling behavior Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000001988 urethral stricture Diseases 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
- A61M35/006—Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1089—Urethra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/14—Female reproductive, genital organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/16—Male reproductive, genital organs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Plant Substances (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461943287P | 2014-02-21 | 2014-02-21 | |
| US61/943,287 | 2014-02-21 | ||
| US201462082019P | 2014-11-19 | 2014-11-19 | |
| US62/082,019 | 2014-11-19 | ||
| PCT/US2015/017151 WO2015127390A1 (en) | 2014-02-21 | 2015-02-23 | Method for maintenance of urethral catheters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2939940A1 CA2939940A1 (en) | 2015-08-27 |
| CA2939940C true CA2939940C (en) | 2023-10-03 |
Family
ID=52814179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2939940A Active CA2939940C (en) | 2014-02-21 | 2015-02-23 | Method for maintenance of urethral catheters |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10046137B2 (enExample) |
| EP (1) | EP3107612B1 (enExample) |
| JP (2) | JP6335337B2 (enExample) |
| CN (1) | CN106029156A (enExample) |
| AU (2) | AU2015218703A1 (enExample) |
| CA (1) | CA2939940C (enExample) |
| ES (1) | ES3038242T3 (enExample) |
| IL (2) | IL247070B (enExample) |
| LU (1) | LU92856B1 (enExample) |
| MX (1) | MX2016010864A (enExample) |
| WO (1) | WO2015127390A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015127390A1 (en) | 2014-02-21 | 2015-08-27 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| CA2968525A1 (en) | 2014-11-19 | 2016-05-26 | Avadim Technologies, Inc. | Method for the prevention and treatment of acne |
| JP7541926B6 (ja) * | 2018-05-22 | 2024-09-10 | シー・アール・バード・インコーポレーテッド | 尿サンプリングキット及びその方法 |
| EP3784322B1 (en) | 2018-05-22 | 2023-11-22 | C. R. Bard, Inc. | Catheterization system and methods for use thereof |
| WO2020033752A1 (en) | 2018-08-10 | 2020-02-13 | C. R. Bard, Inc. | Automated urine-output-measurement systems and methods thereof |
| EP3982909A4 (en) * | 2019-06-12 | 2023-11-29 | Avadim Health, Inc. | COMPOSITIONS AND METHODS FOR ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE |
| US12083261B2 (en) | 2020-06-05 | 2024-09-10 | C. R. Bard, Inc. | Automated fluid output monitoring |
| US11703365B2 (en) | 2020-07-14 | 2023-07-18 | C. R. Bard, Inc. | Automatic fluid flow system with push-button connection |
| US12055249B2 (en) | 2020-07-21 | 2024-08-06 | C. R. Bard, Inc. | Automatic fluid flow system with retractable connection |
| US12408853B2 (en) | 2020-12-17 | 2025-09-09 | C. R. Bard, Inc. | Smart bag to measure urine output via catheter |
| US12364423B2 (en) | 2020-12-21 | 2025-07-22 | C. R. Bard, Inc. | Automated urinary output-measuring systems and methods |
| US11931151B2 (en) | 2020-12-22 | 2024-03-19 | C. R. Bard, Inc. | Automated urinary output measuring system |
| US12246146B2 (en) | 2020-12-23 | 2025-03-11 | C. R. Bard, Inc. | Automated weight based fluid output monitoring system |
| US20220323715A1 (en) * | 2021-04-12 | 2022-10-13 | Hill-Rom Services, Inc. | Optimized catheter usage |
| US12446813B2 (en) | 2021-08-23 | 2025-10-21 | C. R. Bard, Inc. | Automated urine output system for attachment to hospital bed |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB241456A (en) | 1924-11-19 | 1925-10-22 | Singer Mfg Co | Improvements in electric motor controllers |
| US3557006A (en) | 1967-11-24 | 1971-01-19 | Peter J Ferrara | Composite toilet soap bar having an acid ph in use |
| US4784647A (en) | 1986-07-30 | 1988-11-15 | The Kendal Company | Catheter meatal pad device |
| CA2183661A1 (en) | 1994-02-28 | 1995-08-31 | Susan Skewes | Method and system for cleansing the skin |
| US5945409A (en) | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
| US5624704A (en) | 1995-04-24 | 1997-04-29 | Baylor College Of Medicine | Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent |
| US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| US6358516B1 (en) * | 1998-08-21 | 2002-03-19 | Norris R. Harod | One-step system for cleansing, conditioning, and treating the skin |
| US20030185704A1 (en) * | 2000-01-12 | 2003-10-02 | Suzanne Bernard | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| US20060122082A1 (en) | 2000-02-17 | 2006-06-08 | Leonard Paul | Foam/spray producing compositions and dispensing system therefor |
| FR2813189B1 (fr) | 2000-08-31 | 2003-02-28 | Oreal | Creme cosmetique moussante pour le traitement des peaux grasses |
| US6518229B2 (en) | 2000-12-06 | 2003-02-11 | Playtex Products, Inc. | Antibacterial composition comprising an amphoteric/anionic surfactant mixture |
| US6579543B1 (en) | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
| EP1442753B1 (en) | 2003-02-03 | 2007-02-21 | Polaschegg, Hans-Dietrich, Dr.techn. | Composition for the prevention of indwelling device related infection |
| US7947021B2 (en) | 2003-05-08 | 2011-05-24 | Boston Scientific Scimed, Inc. | Antimicrobially-charged entry port cuff |
| US7635358B2 (en) | 2003-10-15 | 2009-12-22 | Boston Scientific Scimed, Inc. | Medical device having anti-microbial properties and a false lumen and method of making the same |
| US20080177217A1 (en) | 2004-05-14 | 2008-07-24 | Hans-Dietrich Polaschegg | Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation |
| US7592326B2 (en) | 2004-03-15 | 2009-09-22 | Karaolis David K R | Method for stimulating the immune, inflammatory or neuroprotective response |
| US8414547B2 (en) | 2004-04-29 | 2013-04-09 | C. R. Bard, Inc. | Modulating agents for antimicrobial coatings |
| US20110129552A1 (en) | 2009-12-01 | 2011-06-02 | Laderma Pty Ltd | Acne Treatment |
| US20060074029A1 (en) | 2004-10-04 | 2006-04-06 | Scott Leece | Topical antimicrobial composition having improved moisturization properties |
| CA2623576A1 (en) | 2005-09-21 | 2007-03-29 | Novabay Pharmaceuticals, Inc. | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| US20070071705A1 (en) | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
| TWI432231B (zh) * | 2005-10-06 | 2014-04-01 | Novabay Pharmaceuticals Inc | 使用ｎ-鹵化胺基酸於預防包括泌尿道感染（ｕｔｉ）之細菌性與真菌性感染的系統與方法 |
| US7655831B2 (en) * | 2005-10-19 | 2010-02-02 | Prywes Arnold S | Method for fluid control in medical applications |
| ZA200711041B (en) | 2005-10-24 | 2009-08-26 | Teikoku Pharma Usa Inc | Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| US8328792B2 (en) | 2005-10-27 | 2012-12-11 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
| US9127045B2 (en) | 2005-11-17 | 2015-09-08 | University Of Southern California | Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides |
| WO2007076162A2 (en) | 2005-12-29 | 2007-07-05 | Kansas State University Research Foundation | Antimicrobial cathelicidin peptides |
| WO2007082061A2 (en) | 2006-01-11 | 2007-07-19 | Hyperbranch Medical Technology, Inc. | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices |
| US20070160559A1 (en) | 2006-01-12 | 2007-07-12 | Roszell James A | Skin disinfectant composition and methods for using |
| US20070224288A1 (en) | 2006-03-22 | 2007-09-27 | Kiss Nail Products, Inc. | Antibacterial gel coating and pedicure spa with antibacterial function |
| US8124096B2 (en) | 2006-07-31 | 2012-02-28 | 3M Innovative Properties Company | Immune response modifier compositions and methods |
| US8784893B2 (en) | 2007-02-05 | 2014-07-22 | Carbylan Therapeutics, Inc. | Polymer formulations for delivery of bioactive agents |
| US7749330B2 (en) | 2007-03-30 | 2010-07-06 | Ethicon, Inc. | Washer and decontaminator with lid control |
| US20080275113A1 (en) | 2007-05-04 | 2008-11-06 | Thomas Edward Huetter | Antimicrobial Compositions, Products, And Methods Of Use |
| US7850998B2 (en) | 2007-07-18 | 2010-12-14 | Kiani Iraj E | Method of treating viral conditions |
| US20100204117A1 (en) | 2007-09-11 | 2010-08-12 | Dorian Bevec | Cgrp as a therapeutic agent |
| ES2378479T3 (es) | 2007-10-03 | 2012-04-12 | Astra Tech Ab | Receptáculo de catéter dotado de un compuesto antimicrobiano |
| EP2065029B1 (en) | 2007-11-30 | 2013-04-17 | Evonik Goldschmidt GmbH | Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K |
| US9072292B2 (en) | 2008-06-06 | 2015-07-07 | T. Brian Cavitt | Biofilm resistant polymer materials |
| CA2727432C (en) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| US9814737B2 (en) | 2010-04-27 | 2017-11-14 | Mercy Medical Research Institute | Composition for skin sanitization and protection and method of its use |
| US20130085093A1 (en) * | 2010-05-14 | 2013-04-04 | Yuken Industry Co., Ltd. | Aqueous cleaning agent composition |
| US9309019B2 (en) | 2010-05-21 | 2016-04-12 | Adhezion Biomedical, Llc | Low dose gamma sterilization of liquid adhesives |
| GB2481456A (en) | 2010-06-25 | 2011-12-28 | Colin Freeman | A cleaning pad |
| US20120100183A1 (en) | 2010-10-23 | 2012-04-26 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| US8911424B2 (en) | 2011-02-09 | 2014-12-16 | Ethicon, Inc. | Methods and devices for preventing catheter related urinary tract infections |
| US9549905B2 (en) | 2011-03-23 | 2017-01-24 | The Regents Of The University Of California | Treatment of inflammatory and infectious skin disorders |
| WO2012132774A1 (ja) * | 2011-03-29 | 2012-10-04 | テルモ株式会社 | 薬剤組成物塗布デバイス |
| CN202061232U (zh) * | 2011-04-12 | 2011-12-07 | 郭淑艳 | 泌尿外科用尿道口消毒装置 |
| US9327029B2 (en) | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
| EP2709632A4 (en) | 2011-05-16 | 2015-03-04 | Dale L Pearlman | COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES |
| EP2714543B1 (en) * | 2011-05-31 | 2019-07-03 | CompactCath, Inc. | Compact catheter assembly |
| WO2012177433A1 (en) | 2011-06-21 | 2012-12-27 | Evologie Llc | Topical compositions for the treatment of dermatological disorders |
| US9717757B1 (en) | 2011-12-28 | 2017-08-01 | Samuel N. Gasque, Jr. | Composition and method to treat and prevent muscle cramping |
| WO2013142374A1 (en) | 2012-03-23 | 2013-09-26 | Amirobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
| GB2511350B (en) | 2013-03-01 | 2016-11-09 | Reckitt Benckiser Brands Ltd | Skincare compositions |
| WO2015127390A1 (en) | 2014-02-21 | 2015-08-27 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| US20160158393A1 (en) | 2014-02-21 | 2016-06-09 | Avadim Technologies, Inc. | Method for Improving Health Outcomes |
| US20150242213A1 (en) | 2014-02-23 | 2015-08-27 | Qualcomm Incorporated | System and method for modification of coded instructions in read-only memory using one-time programmable memory |
| CA2968525A1 (en) | 2014-11-19 | 2016-05-26 | Avadim Technologies, Inc. | Method for the prevention and treatment of acne |
| MX2017016911A (es) | 2015-06-19 | 2019-06-24 | Avadim Tech Inc | Método para mejorar resultados en la salud. |
| WO2017097434A1 (en) | 2015-12-06 | 2017-06-15 | Symrise Ag | A fragrance composition |
-
2015
- 2015-02-23 WO PCT/US2015/017151 patent/WO2015127390A1/en not_active Ceased
- 2015-02-23 EP EP15714693.7A patent/EP3107612B1/en active Active
- 2015-02-23 AU AU2015218703A patent/AU2015218703A1/en not_active Abandoned
- 2015-02-23 ES ES15714693T patent/ES3038242T3/es active Active
- 2015-02-23 US US14/629,320 patent/US10046137B2/en active Active
- 2015-02-23 JP JP2016570926A patent/JP6335337B2/ja active Active
- 2015-02-23 LU LU92856A patent/LU92856B1/xx active
- 2015-02-23 MX MX2016010864A patent/MX2016010864A/es unknown
- 2015-02-23 CN CN201580009856.8A patent/CN106029156A/zh active Pending
- 2015-02-23 CA CA2939940A patent/CA2939940C/en active Active
-
2016
- 2016-08-02 IL IL247070A patent/IL247070B/en active IP Right Grant
-
2017
- 2017-07-18 IL IL253561A patent/IL253561A0/en unknown
-
2018
- 2018-02-01 JP JP2018016713A patent/JP2018115163A/ja active Pending
- 2018-08-03 US US16/054,017 patent/US11925768B2/en active Active
-
2020
- 2020-01-09 AU AU2020200171A patent/AU2020200171A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180344972A1 (en) | 2018-12-06 |
| CA2939940A1 (en) | 2015-08-27 |
| LU92856B1 (en) | 2016-02-21 |
| JP2017513920A (ja) | 2017-06-01 |
| US11925768B2 (en) | 2024-03-12 |
| IL253561A0 (en) | 2017-09-28 |
| WO2015127390A1 (en) | 2015-08-27 |
| MX2016010864A (es) | 2017-05-08 |
| IL247070B (en) | 2019-02-28 |
| AU2015218703A1 (en) | 2016-09-22 |
| EP3107612A1 (en) | 2016-12-28 |
| JP6335337B2 (ja) | 2018-05-30 |
| US10046137B2 (en) | 2018-08-14 |
| JP2018115163A (ja) | 2018-07-26 |
| ES3038242T3 (en) | 2025-10-10 |
| EP3107612B1 (en) | 2025-05-21 |
| CN106029156A (zh) | 2016-10-12 |
| US20150343172A1 (en) | 2015-12-03 |
| AU2020200171A1 (en) | 2020-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11925768B2 (en) | Method for decolonizing mammalian skin | |
| DeSanti | Pathophysiology and current management of burn injury | |
| CA2989644A1 (en) | Method for improving health outcomes | |
| EP2563356A2 (en) | A composition for skin sanitization and protection and method of its use | |
| US20200306394A1 (en) | Methods for improving integumentary tissue by topically applying acidifying compositions | |
| EP2320915B1 (en) | Gentle, non-irritating, non-alcohoholic skin disinfectant | |
| US8173147B2 (en) | Gentle, non-irritating, non-alcoholic skin disinfectant | |
| US20160184220A1 (en) | Method for the Prevention and Treatment of Acne | |
| HK1229737A1 (en) | Method for maintenance of urethral catheters | |
| Percival | Wounds and infection | |
| Kavathekar et al. | Evaluation of clinical efficacy and safety of PureHands in hand hygiene | |
| Cohen | Proper hand washing protocols: Critical for preventing nosocomial infections | |
| Marchand et al. | INTRODUCTION EN CLINIQUE D'UN BROSSAGE PRÉ-CHIRURGICAL SANS BROSSE À BASE DE CHLORHEXIDINE/ÉTHANOL/CLINICAL IMPLEMENTATION OF A SCRUBLESS CHLORHEXIDINE/ETHANOL PRE-OPERATIVE SURGICAL HAND RUB | |
| CN107496247A (zh) | 一种祛痘组合物及含有该组合物的护肤品 | |
| HK1158926B (en) | Gentle, non-irritating, non-alcohoholic skin disinfectant | |
| AU2013205413A1 (en) | Gentle, Non-Irritating, Non-Alcoholic Skin Disinfectant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |
|
| EEER | Examination request |
Effective date: 20200219 |